COLO-205  Xenografts

 

 

Rincon Bio performs COLO-205 xenograft models to test efficacy of preclinical therapies.  Please see below for additional information or to request a quote. 

Colon

COLO-205 cells were derived from a 70 year old Caucasian male with carcinoma of the colon

Oncogene

Carcinoembryonic antigen (CEA) 1.5 to 4.1 ng/10 exp6 cells/10 days; keratin; interleukin 10 (IL-10, interleukin-10),The cells are positive for keratin by immunoperoxidase staining.

The cells are CSAp negative (CSAp-).

The cells are positive for keratin by immunoperoxidase staining.

COLO 205 cells express a 36000 dalton cell surface glycoprotein related to the GA733-2 tumor associated antigen. Ref

in vivo

Used in xenografts to test the efficacy of novel cancer therapeutics 

 

Cells grow in nude mice (Tumors develop within 21 days in nude mice inoculated subcutaneously with 10(7) cells). Ref

Request Quote

Receive a quote within one business day for a COLO-205 Xenograft

Rincon Bio Growth Curve

Colo-205

Colo205.png

Cell Line: Colo-205 

Mouse Strain: Athymic Nude Envigo 

Animals per Group: 10 

Positive Control: None 

Concentration: N/A 

Matrigel: Yes 

Dosing: N/A 

From implant to stratification: 7 

Cells Implanted per Animal: 10 million 

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We are easy to work with.  And we take a personal interest in our clients and their studies.